Baeuerle Patrick 4
4 · Harpoon Therapeutics, Inc. · Filed Dec 30, 2019
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Sale
Common Stock
2019-12-27$15.81/sh−75,562$1,194,922→ 273,953 total(indirect: See footnote) - Sale
Common Stock
2019-12-27$18.07/sh−1,400$25,297→ 262,136 total(indirect: See footnote) - Sale
Common Stock
2019-12-27$16.90/sh−10,417$176,062→ 263,536 total(indirect: See footnote)
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $15.51 to $16.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Shares indirectly held by APAK Solutions GmbH, of which the Reporting Person has sole voting and investment power over these shares.
- [F4]Represents the weighted average sales price per share. The shares sold at prices ranging from $16.51 to $17.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F5]Represents the weighted average sales price per share. The shares sold at prices ranging from $17.57 to $18.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.